SEC Form 4 · accession 0001493152-16-007871

Targeted Medical Pharma, Inc. · TRGM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Medical Officer · Director

Period of report

Mar 4, 2016

Accepted (ET)

Mar 7, 2016 · 5:00 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001420030

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Mar 4, 2016	A	575,000	$0.05	A	575,000	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Options to Purchase Common Stock^F3	$3.38	Mar 20, 2010	J	177,469	D	—	—	Common Stock	177,469	1,225,077	D
Options to Purchase Common Stock^F4	$3.38	Dec 21, 2011	J	400,000	D	—	—	Common Stock	400,000	825,077	D
Options to Purchase Common Stock^F1	$0.05	Mar 4, 2016	A	400,000	A	—	Mar 3, 2023	Common Stock	400,000	1,225,077	D

F1The options were issued pursuant to the Company's 2011 Stock Incentive Plan. Options to purchase 400,000 shares vested on March 4, 2016 with a seven year term.
F2Voluntary forfeiture by grantee.
F3The option became exercisable as to 59,157 of the shares on March 20, 2010, and 59,156 shares on March 1, 2011 and 2012. The expiration date for these options is March 20, 2020.
F4The option became exercisable as to 200,000 of the shares on December 21, 2011 and 200,000 shares on December 21, 2012. The expiration date for these options is December 21, 2021.